Scientists reverse Alzheimer's memory loss in mice by using NAD+ to restore brain energy, defying decades of research.

Scientists have created a blood test that can estimate when Alzheimer’s symptoms are likely to begin. By measuring a protein called p-tau217, the model predicts symptom onset within roughly three to ...

Researchers believe the test could be a new way to foresee how quickly the disease will progress, but evidence so far is preliminary. A growing body of research links insulin resistance, a hallmark of ...

The FDA recently cleared the Lumipulse blood test for early diagnosis of Alzheimer's disease in people 55 and over with memory loss. The noninvasive Lumipulse blood test measures the levels of two ...

A team from the University of Barcelona has designed and validated in animal models an innovative compound with a pioneering mechanism of action for the treatment of Alzheimer's disease. Unlike ...

Rising diagnoses of young onset dementia highlight the need for early recognition and timely evaluation of a condition that disrupts patients’ careers, families, and financial stability.

Elevated cardiac troponin I levels during midlife — indicative of subclinical myocardial injury — were associated with a higher risk for dementia, faster cognitive decline, and greater brain atrophy ...

Oral lithium at low doses may help limit deteriorating verbal memory for patients diagnosed with Alzheimer disease.

Eleftheria Kodosaki does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations ...

A growing body of research links insulin resistance, a hallmark of diabetes, to the onset of Alzheimer’s disease. A blood test for insulin resistance can help identify people with early Alzheimer’s ...

A clinical trial suggests that low-dose lithium may slow the decline of verbal memory in older adults with mild cognitive impairment and amyloid-beta.